Generic Razadyne

Razadyne is currently under the protection of a patent that prevents any generic Razadyne from being manufactured in the United States. Many companies claim to sell generic versions of the drug, but these medicines could be fake, substandard, and potentially dangerous. The earliest possible date that an approved generic Razadyne could become available is December 2008, when the patent expires.

 

Razadyne Generic: An Overview

Razadyne® (galantamine hydrobromide) is a prescription Alzheimer's disease medication. It is part of a group of medications known as acetylcholinesterase inhibitors. Razadyne was originally marketed under the name "Reminyl®," but the name was changed after confusion with a similar-sounding medication. Razadyne is available in short-acting forms (tablets and oral solution) and in long-acting Razadyne ER capsules.
 
Razadyne is made by Ortho-McNeil Neurologics. It is currently under the protection of a patent that prevents any generic Razadyne from being manufactured in the United States. Yet if you search the Internet for "generic Razadyne," you may find a number of companies selling it. The fact is that these medicines may be fake, substandard, and potentially dangerous. Generic Razadyne may be available from another country, but there is really no way of knowing if you are getting genuine Razadyne. You should not buy any generic Razadyne until an approved version is available.
 

When Will Generic Razadyne Be Available?

The first patent for Razadyne is set to expire in December 2008. This is the earliest predictable date that a generic version of Razadyne could become available. However, other circumstances could come up to extend or shorten the exclusivity period. This could include such things as other patents for specific Razadyne uses or lawsuits.
 
(Generic Razadyne Continued: Page 2)
Add this article to your Favorites     Email this article     Print
Written by/reviewed by: Kristi Monson, PharmD; Arthur Schoenstadt, MD
Last reviewed by: Kristi Monson, PharmD;